Bruce Turner, Chief Strategy Officer at Immunome Inc. (IMNM), bought 42,300 shares at $5.91 ($250K) on 2023-10-02, disclosed to the SEC on 2023-10-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.